Current FDA approved pharmaceutical treatment for acute ischemia is limited to thrombolytic intervention, which functions to restore blood flow, yet patients often still suffer long term motor, behavioral, and cognitive deficits due to a lack of interventions focused on promoting neuronal post-stroke recovery (Stubblefield and Lechleiter, 2019)
This is because glutathione is notoriously difficult for the body to absorb when taken in a traditional pill or tablet form
It plays a central role in actin regulation, binding to monomeric actin (G-actin) and influencing cytoskeletal remodeling, cell migration, and wound repair processes [7]
Glass vials with rubber stoppers allow repeated needle penetration while maintaining a sealed environment
Sermorelin is typically explored as a truncated analog associated with growth hormonereleasing pathways, while GHRP-2 is examined as a separate peptide that may interact with additional upstream regulatory receptors
This makes them a safe and gentle option for individuals who prefer to avoid harsher skin treatments